Dr. Ingraham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
420 Delaware St Se
Mmc 284
Minneapolis, MN 55455Phone+1 612-626-5031
Summary
- Dr. Nicholas Ingraham is a pulmonary and critical care physician in Minneapolis, MN and is affiliated with University of Minnesota. He received his medical degree from Creighton University School of Medicine and has been in practice 2 years. He specializes in critical care medicine.
Education & Training
- University of Minnesota SystemMS, Clinical Research, 2020 - 2023
- University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 2018 - 2021
- University of MinnesotaResidency, Internal Medicine, 2014 - 2017
- Creighton University School of MedicineClass of 2014
- Marquette UniversityB.S., Physiological Sciences, Cum Laude, 2006 - 2010
Certifications & Licensure
- MN State Medical License 2016 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Alpha Omega Alpha Fellow Nomination University of Minnesota, 2019
- Star Research Award Recipient Society of Critical Care Medicine, 2019
- Jeevan Paul Humanitarian Award University of Minnesota, 2017
- Join now to see all
Publications & Presentations
PubMed
- 33 citationsCharacterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles.Elizabeth R Lusczek, Nicholas E. Ingraham, Basil S. Karam, Jennifer Proper, Lianne Siegel
Plos One. 2021-03-31 - 52 citationsmTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses.Basil S. Karam, Rachel Morris, Carolyn T. Bramante, Michael A. Puskarich, Emily J. Zolfaghari
Journal of Medical Virology. 2021-04-01 - 46 citationsA multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19Michael A. Puskarich, Nathan W. Cummins, Nicholas E. Ingraham, David A. Wacker, Ronald Reilkoff
Eclinicalmedicine. 2021-06-17
Abstracts/Posters
- BetrAID Along the Path to P-roviding J-ust P-atient CareIngraham NE, MacDonald D, Sarosi G, American Thoracic Society Conference, San Diego, CA, 1/1/2018
- A Case of Pulmonary Blastomycosis Induced ARDS with Early Initiation of SteroidsMacDonald D, Ingraham NE, Sarosi G, American Thoracic Society Conference, San Diego, CA, 1/1/2018
- Smoking and Accelerated Lung Function Decline in the START Pulmonary SubstudyMacDonald D, Collins G, Ingraham NE, Melzer A, Crothers K, Avihingsanon A, Mugerwa H, Ristola M, Shuter J, Kunisaki, Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/1/2018
- Join now to see all
Lectures
- Recent Trends in Critical Care Admission Diagnosis and Related MortalityDallas, TX - 1/1/2019
- Dysfunction Junction: 8-year Trends in Deteriorating ICU Functional StatusDallas, TX - 1/1/2019
- Failure to Launch: Predictors of Chronic Critical Illness in Liver Transplant RecipientsSan Diego, CA - 1/1/2019
Press Mentions
- COVID-19 Patients Can Be Categorized into Three Groups – Here Are the 3 PhenotypesApril 17th, 2021
- Study IDs 3 COVID-19 Phenotypes, Could Help Guide CareApril 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: